Screening and Staging of Benign vs Malignant Pelvic Abnormalities
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Non-Interventional Study.
- Who it may be relevant to
- Registry conditions: Endometrial Carcinoma, Prostate Carcinoma. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Clinical Evidence Generation of AI Enabled Fast, Accurate and Precise Screening and Staging of Benign vs Malignant Pelvic Abnormalities
Overview
This study evaluates whether newly developed non-FDA approved image processing techniques \[Adaptive Image Reconstruction (AIR Recon) Deep Learning (DL) and Sonic DL\] can provide improved quality and decreased time compared to current scanning techniques.
Interventions
- Other Non-Interventional Study
Non-interventional study
Primary outcome measures
- Change in image quality (healthy volunteers) [Time frame: Baseline]
- Change in scan time [Time frame: Baseline]
Eligibility criteria
Inclusion criteria
- Patient over the age of 18
- For prostate group, any patient referred for prostate MR for screening purposes with no prior prostate related treatment or prior biopsy
- For endometriosis group, any patient referred for possible endometriosis evaluation (pre-surgical)
Exclusion criteria
- Individuals unable to undergo MRI imaging (MR-conditional or MR-nonconditional devices which would need additional procedures/conditions for scanning, pregnant people, individuals with implanted metal, etc.)
- Patient under the age of 18
- Patient who is unable to consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Case-control
Study locations
United States · 1 center
- Mayo Clinic in Rochester — Rochester
Identifiers
NCT: NCT07407959 · MCBookwalter · NCI-2025-09210 · 24-011490